Evidence has revealed that NDRG3 is a new and useful biomarker for human cancer; however, despite reports that NDRG3 is up-regulated in HCC specimens, its clinicopathological relevance and relationship to HCC prognosis remain unclear. Here, NDRG3 is linked to cancer.